Get the Stockscreener App
4.31
4.01%
-0.18
After Hours:
4.31
Outset Medical Inc stock is traded at $4.31, with a volume of 258.68K.
It is down -4.01% in the last 24 hours and up +18.73% over the past month.
Outset Medical Inc is a medical technology company pioneering a technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
See More
Previous Close:
$4.49
Open:
$4.56
24h Volume:
258.68K
Relative Volume:
1.62
Market Cap:
$79.90M
Revenue:
$117.59M
Net Income/Loss:
$-74.85M
P/E Ratio:
-1.0323
EPS:
-4.175
Net Cash Flow:
$-34.25M
1W Performance:
-0.23%
1M Performance:
+18.73%
6M Performance:
+8.56%
1Y Performance:
-78.41%
1-Day Range:
$4.17
$4.59
1-Week Range:
$4.17
$4.80
52-Week Range:
$3.00
$21.36
Outset Medical Inc Stock (OM) Company Profile
Name
Outset Medical Inc
Sector
Industry
Phone
669-231-8200
Address
3052 ORCHARD DRIVE, SAN JOSE
Compare OM vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OM
Outset Medical Inc
|
4.31 | 83.23M | 117.59M | -74.85M | -34.25M | -4.175 |
ABT
Abbott Laboratories
|
88.67 | 153.59B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.94 | 119.69B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
80.38 | 102.97B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
46.76 | 69.72B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.28 | 49.01B | 6.30B | 1.07B | 1.09B | 1.8406 |
Outset Medical Inc Stock (OM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-08-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jun-21-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Apr-08-24 | Initiated | BTIG Research | Buy |
| Apr-05-24 | Upgrade | CL King | Neutral → Buy |
| Jan-12-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Oct-13-23 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-17-23 | Initiated | CL King | Neutral |
| Nov-11-22 | Initiated | RBC Capital Mkts | Outperform |
| Jul-14-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-17-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-18-21 | Initiated | Cowen | Outperform |
| Apr-19-21 | Initiated | Wells Fargo | Overweight |
| Dec-16-20 | Initiated | Oppenheimer | Perform |
| Oct-12-20 | Initiated | Barclays | Overweight |
| Oct-12-20 | Initiated | BofA Securities | Buy |
| Oct-12-20 | Initiated | Goldman | Buy |
| Oct-12-20 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-12-20 | Initiated | SVB Leerink | Mkt Perform |
| Oct-12-20 | Initiated | Stifel | Buy |
View All
Outset Medical Inc Stock (OM) Latest News
Outset Medical, Inc. (OM) reports Q1 loss, lags revenue estimates - MSN
Outset Medical Inc. (OM) Q1 2026 Earnings: Wider-than-Expected Loss Weighs on SharesEnergy Earnings Report - newsline.com
Have Insiders Sold Outset Medical Shares Recently? - simplywall.st
Outset Medical Inc. Q1 2026 Earnings: EPS Misses Estimates, Stock Declines 3.17%Share Dilution Risk - newsline.com
Outset Medical CFO Renee Gaeta sells $87,299 in stock - Investing.com UK
Law firm investigates Outset Medical officers for possible shareholder duty breaches - Pluang
Director at Outset Medical (OM) receives 10,667-share stock grant - Stock Titan
Outset Medical CFO Renee Gaeta sells $87,299 in stock By Investing.com - Investing.com Canada
Outset Medical (NYSE: OM) director granted 10,667 RSUs in new equity award - Stock Titan
Outset Medical (OM) director receives 10,667-share RSU equity grant - Stock Titan
Outset Medical (OM) director receives 10,667-share RSU-based award - Stock Titan
Outset Medical (OM) director receives 10,667-share equity award grant - Stock Titan
Outset Medical director granted 10,667 shares | OM Insider Trading - Stock Titan
Outset Medical (OM) CFO tax-related share sale follows RSU vesting - Stock Titan
Outset Medical (NASDAQ: OM) reports 2026 shareholder meeting vote results - Stock Titan
Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - Barchart.com
BML Capital Management, LLC's Outset Medical Inc(OM) Holding History - GuruFocus
Outset Medical names Derick Elliott commercial chief - Investing.com
OM (NASDAQ) Form 144 notice — 32,856 shares settled from RSUs - Stock Titan
DaVita Gains 21.4% in Three Months: How Should You Play the Stock? - TradingView
Outset Medical, Inc. (OM) Reports Q1 Loss, Lags Revenue Estimates - Eastern Progress
Outset Medical's Marc Nash to Depart as Executive Vice President, R&D, Operations and Service - TradingView
[8-K] Outset Medical, Inc. Reports Material Event - Stock Titan
Outset Medical, Inc. Announces Resignation of Marc Nash from Executive Vice President, R&D, Operations and Service, Effective June 5, 2026 - marketscreener.com
Why Did Outset Medical Stock Tumble Today? - MSN
Outset Medical Inc. (OM) Edges Higher as Stock Holds Above Key Support LevelHigh Volume Stocks - The Legal Advocate
Outset Medical Q1 2026 Earnings: EPS Misses Estimates, Stock Edges HigherEarnings Yield Analysis - thelegaladvocate.com
OM Q1 2026 Earnings: EPS Misses Estimates as Outset Medical Posts Wider-Than-Expected Loss; Stock Edges Up - newsline.com
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Outset Medical (OM) Price Target Decreased by 38.83% to 16.06 - MSN
Outset Medical: General counsel Brottem sells $9,760 in shares - Investing.com India
Outset Medical CEO Leslie Trigg sells $12,746 in OM shares - Investing.com India
Outset Medical EVP Marc Nash sells $5,853 in common stock - Investing.com India
Outset Medical EVP Marc Nash sells $5,853 in common stock By Investing.com - Investing.com South Africa
Outset Medical: General counsel Brottem sells $9,760 in shares By Investing.com - Investing.com South Africa
Outset Medical CEO Leslie Trigg sells $12,746 in OM shares By Investing.com - Investing.com Nigeria
Outset Medical (OM) EVP sells 1,582 shares in tax-related ‘sell to cover’ - Stock Titan
BML Investment Partners takes 13.6% stake in Outset Medical (OM) - Stock Titan
Outset Medical (OM) major holder assigned 323K shares via June 2026 puts - Stock Titan
Outset Medical (OM) price target decreased by 14.81% to 7.82 - MSN
OM (NASDAQ: OM) settles 4,277 RSUs; Marc Nash sold 1,830 shares earlier - Stock Titan
OM (NASDAQ: OM) files Form 144 for 9,319 RSU settlement on 05/15/2026 - Stock Titan
OM (NASDAQ) director files Form 144 reporting 5,033 RSUs settled and prior sale - Stock Titan
Outset Medical (OM) amendment shows no beneficial ownership by Alyeska entities - Stock Titan
Woodline Partners holds 292,437 OM shares (1.6%) (OM) - Stock Titan
BTIG Maintains Outset Medical (OM) Buy Recommendation - MSN
Outset Medical (OM) Q1 2026 Earnings Transcript - AOL.com
Here’s Why Outset Medical (OM) Rebound Sharply After Last Quarter’s Selloff - Insider Monkey
Outset Medical Inc Stock (OM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):